<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Immunol.</journal-id>
<journal-title>Frontiers in Immunology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Immunol.</abbrev-journal-title>
<issn pub-type="epub">1664-3224</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fimmu.2017.01259</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Immunology</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Dual-Specificity Phosphatase 12 Targets p38 MAP Kinase to Regulate Macrophage Response to Intracellular Bacterial Infection</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name><surname>Cho</surname> <given-names>Sharol Su Lei</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<xref ref-type="author-notes" rid="fn001"><sup>&#x02020;</sup></xref>
<uri xlink:href="http://frontiersin.org/people/u/482419"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Han</surname> <given-names>Jian</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<xref ref-type="author-notes" rid="fn001"><sup>&#x02020;</sup></xref>
<uri xlink:href="http://frontiersin.org/people/u/482409"/>
</contrib>
<contrib contrib-type="author">
<name><surname>James</surname> <given-names>Sharmy J.</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<uri xlink:href="http://frontiersin.org/people/u/482379"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Png</surname> <given-names>Chin Wen</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<uri xlink:href="http://frontiersin.org/people/u/482427"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Weerasooriya</surname> <given-names>Madhushanee</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<uri xlink:href="http://frontiersin.org/people/u/482426"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Alonso</surname> <given-names>Sylvie</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<uri xlink:href="http://frontiersin.org/people/u/40317"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name><surname>Zhang</surname> <given-names>Yongliang</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<xref ref-type="corresp" rid="cor1">&#x0002A;</xref>
<uri xlink:href="http://frontiersin.org/people/u/449964"/>
</contrib>
</contrib-group>
<aff id="aff1"><sup>1</sup><institution>Department of Microbiology and Immunology, Yong Loo Lin School of Medicine</institution>, <addr-line>Singapore</addr-line>, <country>Singapore</country></aff>
<aff id="aff2"><sup>2</sup><institution>Immunology Programme, Life Science Institute, National University of Singapore</institution>, <addr-line>Singapore</addr-line>, <country>Singapore</country></aff>
<author-notes>
<fn fn-type="edited-by"><p>Edited by: Uday Kishore, Brunel University London, United Kingdom</p></fn>
<fn fn-type="edited-by"><p>Reviewed by: Kushagra Bansal, Harvard Medical School, United States; Ashley Mansell, Hudson Institute of Medical Research, Australia</p></fn>
<corresp content-type="corresp" id="cor1">&#x0002A;Correspondence: Yongliang Zhang, <email>miczy&#x00040;nus.edu.sg</email></corresp>
<fn fn-type="other" id="fn001"><p><sup>&#x02020;</sup>These authors have contributed equally to this work.</p></fn>
<fn fn-type="other" id="fn002"><p>Specialty section: This article was submitted to Molecular Innate Immunity, a section of the journal Frontiers in Immunology</p></fn>
</author-notes>
<pub-date pub-type="epub">
<day>09</day>
<month>10</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="collection">
<year>2017</year>
</pub-date>
<volume>8</volume>
<elocation-id>1259</elocation-id>
<history>
<date date-type="received">
<day>23</day>
<month>06</month>
<year>2017</year>
</date>
<date date-type="accepted">
<day>21</day>
<month>09</month>
<year>2017</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#x000A9; 2017 Cho, Han, James, Png, Weerasooriya, Alonso and Zhang.</copyright-statement>
<copyright-year>2017</copyright-year>
<copyright-holder>Cho, Han, James, Png, Weerasooriya, Alonso and Zhang</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/"><p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p></license>
</permissions>
<abstract>
<p>The mitogen-activated protein kinase (MAPK) cascades are activated in innate immune cells such as macrophages upon the detection of microbial infection, critically regulating the expression of proinflammatory cytokines and chemokines such as TNF-&#x003B1;, IL-6, and MCP-1. As a result, activation of MAPKs is tightly regulated to ensure appropriate and adequate immune responses. Dual-specificity phosphatases (DUSPs) are a family of proteins which specifically dephosphorylates threonine and tyrosine residues essential for MAPK activation to negatively regulate their activation. DUSP12 is a member of atypical DUSPs that lack MAPK-binding domain. Its substrate and function in immune cells are unknown. In this study, we demonstrated that DUSP12 is able to interact with all the three groups of MAPKs, including extracellular signal-regulated protein kinase, JNK, and p38. To investigate the function of DUSP12 in macrophages in response to TLR activation and microbial infection, we established RAW264.7 cell lines stably overexpressing DUSP12 and found that overexpression of DUSP12 inhibited proinflammatory cytokine and chemokine production in response to TLR4 activation, heat-inactivated <italic>Mycobacterium tuberculosis</italic> stimulation as well as infections by intracellular bacteria including <italic>Listeria moncytogenesis</italic> and <italic>Mycobacterium bovis</italic> BCG by specifically inhibiting p38 and JNK. In addition, a scaffold protein known as signal transducing adaptor protein 2 (STAP2), was found to mediate the interaction between DUSP12 and p38. Thus, DUSP12 is a bona fide MAPK phosphatase, playing an important role in MAPK-regulated responses to bacterial infection. Our study provides a model where atypical DUSPs regulate MAPKs <italic>via</italic> scaffold, thereby regulating immune responses to microbial infection.</p>
</abstract>
<kwd-group>
<kwd>dual-specificity phosphatase</kwd>
<kwd>MAP kinases</kwd>
<kwd>inflammatory cytokine</kwd>
<kwd>macrophages</kwd>
<kwd>toll-like receptor signaling</kwd>
<kwd>bacterial infections</kwd>
</kwd-group>
<counts>
<fig-count count="6"/>
<table-count count="0"/>
<equation-count count="0"/>
<ref-count count="38"/>
<page-count count="12"/>
<word-count count="8428"/>
</counts>
</article-meta>
</front>
<body>
<sec id="S1" sec-type="introduction">
<title>Introduction</title>
<p>The innate immune system is the first line of defense against microbe infection. It responses rapidly upon pathogen recognition and triggering inflammation. The pathogen-associated molecular patterns (PAMPs) derived from invading pathogens can be recognized by a family of transmembrane pattern recognition receptors (PRRs) called Toll-like receptors (TLRs) located on the cellular surface or endosomes of immune cells. There are 10 and 12 functional TLRs identified in human and mouse, respectively, each recognizing different ligands (<xref ref-type="bibr" rid="B1">1</xref>, <xref ref-type="bibr" rid="B2">2</xref>). Pathogens may present various ligands which can be recognized by multiple TLRs. For instance, <italic>Listeria monocytogenes</italic>, a gram-positive intracellular bacterium, expresses a myriad of TLR ligands, including peptidoglycan, flagellin, and bacterial DNA. Therefore, recognition of peptidoglycan by a heterodimer of TLR2 and TLR6, lipoteichoic acid by TLR4, flagellin by TLR5, and bacterial DNA by TLR9 lead to the detection of invading <italic>L. monocytogenes</italic> by innate immune cells and activate the overall immune response (<xref ref-type="bibr" rid="B3">3</xref>&#x02013;<xref ref-type="bibr" rid="B5">5</xref>).</p>
<p>Toll-like receptor activation leads to the initiation of two important signaling cascades, the MyD88-dependent and the MyD88-independent, which in turn, trigger proinflammatory responses (<xref ref-type="bibr" rid="B6">6</xref>). Both signaling cascades lead to the activation of the mitogen-activated protein kinases (MAPKs) which then activate transcription factor AP-1 (<xref ref-type="bibr" rid="B7">7</xref>&#x02013;<xref ref-type="bibr" rid="B9">9</xref>). The MAPK cascade comprises of MAPK kinase kinases (MKKKs), MAPK kinases (MKKs), and MAPKs where their activation relies on sequential phosphorylation of these proteins (<xref ref-type="bibr" rid="B10">10</xref>). The activation of the three major MAPKs, namely the extracellular signal-regulated protein kinases (ERK), the p38 MAP kinases (p38), and the c-Jun NH2-terminal kinases (JNK), requires the phosphorylation of both threonine and tyrosine residues within the Thr-X-Tyr (TXY) motif in their activation loop. The intensity and duration of MAPK activation control the transcription, translation and mRNA stabilization of numerous proinflammatory cytokine and chemokine genes (<xref ref-type="bibr" rid="B11">11</xref>). Therefore, the magnitude and duration of MAPKs activation need to be tightly regulated to ensure controlled immune responses.</p>
<p>Dual-specificity phosphatases (DUSPs) are a family of protein phosphatases which can dephosphorylate both threonine and tyrosine residues in the Thr-X-Tyr (TXY) activation motif of MAPKs. Dephosphorylation negatively regulates the intensity and duration of MAPK activation (<xref ref-type="bibr" rid="B12">12</xref>, <xref ref-type="bibr" rid="B13">13</xref>). DUSPs can be classified into classical or atypical DUSPs based on the presence of a MAPK binding domain (<xref ref-type="bibr" rid="B14">14</xref>). Classical DUSPs, also known as MAPK phosphatases (MKPs), contain a highly conserved C-terminal phosphatase domain and an N-terminal Cdc25 homology domain. The phosphatase domain shows similarity to the prototypic dual-specificity protein phosphatase VH-1 containing a signature catalytic motif &#x0201C;HCxxGxxR&#x0201D; (<xref ref-type="bibr" rid="B15">15</xref>). The Cdc25 homology domain is alternatively known as MAPK binding domain (MKB) and it consists of a kinase-interacting motif (KIM) which is crucial for docking to MAPKs (<xref ref-type="bibr" rid="B16">16</xref>). The atypical DUSPs, on the other hand, lack the N-terminal Cdc25 homology domain and have relatively simpler structure compared to classical DUSPs. Although phylogenetic analysis suggested diverse gene origins among atypical DUSPs, they all contain a conserved phosphatase catalytic site, identical to the one in classical DUSPs (<xref ref-type="bibr" rid="B17">17</xref>). Studies have shown that some atypical DUSPs can regulate the activation of MAPKs despite the lack of MAPK substrate recognition and binding domain (<xref ref-type="bibr" rid="B18">18</xref>, <xref ref-type="bibr" rid="B19">19</xref>). However, functions of these atypical DUSPs in immune responses are largely unknown.</p>
<p>Dual-specificity phosphatase 12 is an atypical DUSP which is highly conserved among mammalian species (<xref ref-type="bibr" rid="B20">20</xref>). It contains a dual-specificity phosphatase catalytic domain, a C2H2 zinc finger domain, and an aldehyde dehydrogenase cysteine (ALDH) active site (<xref ref-type="bibr" rid="B21">21</xref>). Previous studies have shown that DUSP12 can dephosphorylate glucokinase, regulate cell cycle, and is involved in stress-induced cell death and cancer (<xref ref-type="bibr" rid="B22">22</xref>&#x02013;<xref ref-type="bibr" rid="B24">24</xref>). In addition, it has been shown that DUSP12 is generally expressed in many immune cells and tissues (<xref ref-type="bibr" rid="B25">25</xref>). However, its function in immune response is unknown. In this study, we demonstrated that DUSP12 interacts with all three groups of MAPKs in HEK293T cells despite the lack of MKB and the interaction between DUSP12 and p38 was mediated by signal transducing adaptor protein 2 (STAP2). Further, we established DUSP12 stably overexpressing RAW264.7 cell lines and studied the function of this protein in macrophages. Overexpression of DUSP12 suppressed the production of various proinflammatory cytokines and chemokines upon TLR activation or intracellular bacterial infection by <italic>L. monocytogenes</italic> or <italic>Mycobacterium bovis</italic> BCG by inactivating JNK and p38, and defective killing of intracellular pathogens.</p>
</sec>
<sec id="S2" sec-type="materials|methods">
<title>Materials and Methods</title>
<sec id="S2-1">
<title>Cell Culture</title>
<p>RAW264.7 cells and HEK293T cells were grown in complete Gibco<sup>&#x000AE;</sup> RPMI Media 1640 and Gibco<sup>&#x000AE;</sup> DMEM (Invitrogen), respectively, supplemented with 10% heat-inactivated fetal bovine serum (Invitrogen) and 1% penicillin/streptomycin (Invitrogen). The pcDNA control and DUSP12 stably overexpressed cell lines were grown in complete RPMI medium containing 500&#x02009;mg/ml G418 (Sigma). All cells were grown in humidified incubator at 37&#x000B0;C with 5% CO<sub>2</sub>.</p>
</sec>
<sec id="S2-2">
<title>Establishment of DUSP12 Stably Overexpressing RAW263.7 Cell Lines</title>
<p>The pcDNA3.1-DUSP12 and pcDNA3.1 empty vectors were transfected into RAW264.7 cells using Lipofectamine LTX reagents (Invitrogen) following the manufacturer&#x02019;s protocol. Transfected cells were maintained in complete medium containing 500&#x02009;mg/ml G418 and the G418 containing medium was replenished for every three days. After two weeks of selection, individual colony was isolated and subjected to screening <italic>via</italic> quantitative real-time PCR (qRT-PCR) and Western blot to obtain DUSP12 overexpressing cells. Primers used to clone DUSP12 into pcDNA vector: forward primer 5&#x02032;-TGAAGGAAGTGGGCCAATAG-3&#x02032; and reverse primer 5&#x02032;-GACCACAGGAGCACTGTTCA-3&#x02032;.</p>
</sec>
<sec id="S2-3">
<title>Molecular Biology</title>
<p>FLAG-tagged constructs were made using the plasmid pXJ40 backbone (<xref ref-type="bibr" rid="B26">26</xref>). The following primers were used to construct the FLAG-tagged proteins: forward primer 5&#x02032;-CCGGATCCATGATGGCGAAAAAGC-3&#x02032; and reverse primer5&#x02032;-GGGAATTCTCATGCATTGTGTGGATTTTTCTTAAAC-3&#x02032; for full-length STAP1; forwards primer 5&#x02032;-GGGGATCCATGGCCACAGCCCTGA-3&#x02032; and reverse primer 5&#x02032;-GGGAATTCTCAGTGTTCCAGTGCCCTCC-3&#x02032; for full-length STAP2.</p>
</sec>
<sec id="S2-4">
<title>Dual Luciferase Reporter Assay</title>
<p>2&#x02009;&#x000D7;&#x02009;10<sup>5</sup> RAW264.7 cells were cotransfected with 50&#x02009;ng AP-1 reporter construct, 400&#x02009;ng pcDNA-vector, -DUSP12, and -DUSP12-PM together with 10&#x02009;ng of pRL-null plasmid using Lipofectamine LTX reagent (Invitrogen). Equal amounts of pcDNA3.1 empty vector were transfected as control. Reporter activity was determined with Promega Dual Luciferase Assay System (Promega). Firefly luciferase values were normalized for transfection efficiency by means of the <italic>Renilla luciferase</italic> activity that is constitutively expressed by pRL-null.</p>
</sec>
<sec id="S2-5">
<title>Quantitative Real-time PCR</title>
<p>Total mRNA was extracted using Trizol (Invitrogen) and cDNA was synthesized using ImProm-II&#x02122; Reverse Transcription System (Promega). qRT-PCR was performed using CFX connect Real Time System. Relative expression levels of DUSP12, TNF-&#x003B1;, IL-6, IL-1&#x003B2;, MCP-1, and IL-10 were calculated by &#x00394;&#x00394;Ct method and normalized to &#x003B2;-actin. The following mouse specific primers were used: forward primer 5&#x02032;-TGAAGGAACTGGGCCAATAG-3&#x02032;and reverse primer 5&#x02032;-GACCACAGGAGCACTGTTCA-3&#x02032; for DUSP12, forward primer 5&#x02032;-TCCCAGGTTCTCTTCAAGGGA-3&#x02032; and reverse primer 5&#x02032;-GGTGAGGAGCACGTAGTCGG-3&#x02032;for TNF-&#x003B1;, forward primer 5&#x02032;-GATGCTACCAAACTGGATATAATC-3&#x02032;and reverse primer 5&#x02032;-TGTACTCCAGGTAGCTATG-3&#x02032; for IL-6, forward primer 5&#x02032;-CAACCAACAAGTGATATTCTCCATG-3&#x02032; and reverse primer 5&#x02032;-ATCCACACTCTCCAGCTGCA-3&#x02032; for IL-1&#x003B2;, forward primer 5&#x02032;-CTCAGCCAGATGCAGTTAACGCCC-3&#x02032;reverse primer 5&#x02032;-GGTGCTGAAGACCTTAGGGCAGAT-3&#x02032;for MCP-1, forward primer 5&#x02032;-GCTCTTACTGACTGGCATGAG-3&#x02032; and reverse primer 5&#x02032;-CGCAGCTCTAGGAGCATGTG-3&#x02032; for IL-10, forward primer 5&#x02032;-AGCACTGTGTTGGCATAGAGGTC-3&#x02032;reverse primer 5&#x02032;-CTTCTTGGGTATGGAATCCTGTG-3&#x02032;for &#x003B2;-actin.</p>
</sec>
<sec id="S2-6">
<title>Enzyme-Linked Immunosorbent Assay (ELISA)</title>
<p>The concentrations of IL-6 and TNF-&#x003B1; in culture supernatants were determined by IL-6 and TNF-&#x003B1; ELISA kits (BD Pharmingen&#x02122;). MCP-1 concentration was determined using the MCP-1 ELISA kit (eBioscience).</p>
</sec>
<sec id="S2-7">
<title>Western Blot</title>
<p>Proteins were harvested using protein lysis buffer (1&#x02009;M Tris&#x02013;Cl, 5&#x02009;M NaCl, 100% NP-40) containing 1&#x000D7; Halt Protease and Phosphatase Inhibitor Cocktail and 0.5&#x02009;M EDTA (Thermo scientific). Protein samples were subjected to SDS-PAGE and Western blot was performed using the following antibodies: anti-DUSP12 (Santa Cruz, 1:500 dilution), anti- beta actin (Cell signaling, 1:1,000 dilution), anti-ERK (Cell Signaling, 1:1,000 dilution), antiphosphorylated-ERK(Sigma, 1:1,000 dilution), anti-JNK(Cell Signaling, 1:1,000 dilution), antiphosphorylated-JNK (Sigma, 1:1,000 dilution), anti-p38 (Cell Signaling, 1:1,000 dilution), or antiphosphorlated-p38 (Sigma, 1:1,000 dilution). Primary antibodies were detected with either antigoat (Santa Cruz, 1:4,000 dilution) or anti-rabbit IgG (Cell Signaling, 1:4,000 dilution) horseradish peroxidase-coupled secondary antibodies. Images were captured using Amersham<sup>&#x000AE;</sup> Hyperfilm<sup>&#x000AE;</sup> ECL&#x02122; and MP Autoradiography Films (GE Healthcare).</p>
</sec>
<sec id="S2-8">
<title>Immunoprecipitation</title>
<p>Flag-tagged or HA-tagged vectors were transiently transfected or cotransfected into 293T cells using Mirus. Proteins were harvested using protein lysis buffer (1&#x02009;M Tris&#x02013;Cl, 5&#x02009;M NaCl, 100% NP-40) containing 1&#x000D7; Halt Protease and Phosphatase Inhibitor Cocktail and 0.5&#x02009;M EDTA (Thermo scientific) 36&#x02009;h after transfection. From the protein lysate, 12.5% was used for WCL, while 75% was used for immunoprecipitation. Protein lysates were incubated with anti-Flag M2 beads overnight at 4&#x000B0;C on a shaker. After the protein binding M2 beads had been washed extensively using lysis buffer, 4&#x000D7; loading dye was added to resuspend the M2 beads and elute bound proteins. The samples were subjected to SDS-PAGE and Western blot was performed with respective antibodies.</p>
</sec>
<sec id="S2-9">
<title><italic>Listeria</italic> Intracellular Killing Assay</title>
<p>The cells were washed twice with PBS and infected with <italic>L. monocytogenes</italic> at the bacteria-to-cell ratio 10:1 in antibiotics-free RPMI medium. After 1&#x02009;h infection, cells were washed with PBS twice to remove extracellular <italic>L. monocytogenes</italic>. Cells were incubated in RPMI medium containing 5&#x02009;&#x003BC;g/ml gentamicin for another 6 or 12&#x02009;h and lysed by 200&#x02009;&#x003BC;l 0.2% Triton X-100 in distilled water. The lysates containing <italic>L. monocytogenes</italic> were plated on Brain Heart Infusion (BHI) agar plates. The BHI agar plates were incubated overnight at 37&#x000B0;C and colony forming units (CFU) were counted.</p>
</sec>
<sec id="S2-10">
<title><italic>Mycobacterium</italic> Intracellular Infection Assay</title>
<p>The macrophages were seeded a day prior to infection at a cell density of 5&#x02009;&#x000D7;&#x02009;10<sup>4</sup>&#x02009;cells/well. Infection was conducted at a multiplicity-of-infection 8 using <italic>M. bovis BCG</italic>. After an hour of infection, cells were washed with PBS to remove extracellular bacteria and media was replaced with RPMI media containing 10% fetal bovine serum. BCG was harvested at various time-points&#x02014;days 0, 1, 2, 5, and 7. Cells were lysed with 0.1% Triton X-100 and lysates were plated on Middlebrook&#x02019;s 7H11 agar plates. The plates were incubated at 37&#x000B0;C for 16&#x02009;days and colony forming units (CFU) were recorded.</p>
</sec>
<sec id="S2-11">
<title>Heat-Inactivated <italic>Mycobacterium tuberculosis</italic> Stimulation Assay</title>
<p>The macrophages were seeded a day prior to infection at a cell density of 1.5&#x02009;&#x000D7;&#x02009;10<sup>6</sup>&#x02009;cells/well. Infection was conducted at a multiplicity-of-infection 8 using heat-inactivated <italic>M. tuberculosis</italic>. Cells were treated with Trizol at 3 and 6&#x02009;h post-stimulation to conduct qRT-PCR to assess cytokine expression. Cell supernatant was collected to measure cytokine expression <italic>via</italic> ELISA.</p>
</sec>
<sec id="S2-12">
<title>Cell Proliferation Assay</title>
<p>The cells were washed twice with PBS and infected with <italic>L. monocytogenes</italic> at the bacteria-to-cell ratio 10:1 in antibiotics-free RPMI medium. After 1&#x02009;h infection, cells were washed twice to remove extracellular Listeria. Cells were incubated in RPMI medium containing 5&#x02009;&#x003BC;g/ml gentamicin for another 24 or 48&#x02009;h. At respective time-points, cells were washed twice with PBS to remove dead floating cells. Cell proliferation was determined by crystal violet staining. Absorbance was measured at 590&#x02009;nm. Percentage of cell survival was obtained by comparing absorbance of infected to that of uninfected cells.</p>
</sec>
<sec id="S2-13">
<title>Statistical Analysis</title>
<p>Data were expressed as the mean&#x02009;&#x000B1;&#x02009;SE. Data comparisons were made with Student&#x02019;s <italic>t</italic>-test or two-way ANOVA using Microsoft Excel and GraphPad PRISM. Differences were considered significant when the <italic>P</italic> value is &#x0003C;0.05. <italic>P</italic>-values &#x0003C;0.05, 0.01, and 0.001 were represented by &#x0201C;&#x0002A;,&#x0201D; &#x0201C;&#x0002A;&#x0002A;,&#x0201D; and &#x0201C;&#x0002A;&#x0002A;&#x0002A;,&#x0201D; respectively.</p>
</sec>
</sec>
<sec id="S3">
<title>Results</title>
<sec id="S3-1">
<title>DUSP12 Interacted with MAPKs and Inhibited AP-1 Promoter Activity</title>
<p>Mitogen-activated protein kinase-binding domain is essential for MAPK interaction and substrate specificity in typical DUSPs. Despite the absence of the binding domain, atypical DUSPs, such as DUSP14, had demonstrated marked ability in dephosphorylating MAPKs (<xref ref-type="bibr" rid="B18">18</xref>). Similarly, DUSP12 lacks the MKB domain and thus we examined DUSP12&#x02019;s ability to interact with MAPKs. Mouse full-length DUSP12 was cloned into pcDNA vectors and transfected into HEK293T cells to examine its ability to bind endogenously to MAPKs. We found that DUSP12 was able to interact with endogenous p38, ERK, and JNK (Figure <xref ref-type="fig" rid="F1">1</xref>A). To examine the role of DUSP12 in innate immunity, we first examined the expression of DUSP12 in RAW264.7 cells, an immortalized murine macrophage cell line, in response to LPS stimulation. The activation of TLR4 will initiate a downstream MAPK signaling cascade which eventually activates transcription factor, AP-1. MKP5, a typical DUSP, serves as a positive control where its expression and function in macrophages have been examined in an earlier study (<xref ref-type="bibr" rid="B27">27</xref>). We found that LPS stimulation resulted in the upregulation of DUSP12 expression in macrophages (Figure <xref ref-type="fig" rid="F1">1</xref>B), although the upregulation appeared to be weaker as compared to that of MKP5. To examine if DUSP12 regulates MAPK-mediated response in immune cells, we performed a dual-luciferase assay by cotransfecting pcDNA vector carrying murine DUSP12 cDNA sequence and a vector consisting of the promoter construct of transcription factor AP-1 conjoined to the luciferase gene. The DUSP12 construct with a point mutation in the catalytic site serves as a negative control. As shown in Figure <xref ref-type="fig" rid="F1">1</xref>C, overexpression of functional DUSP12 inhibited AP-1 promoter activity in response to LPS stimulation, whereas the DUSP12 mutant lost the inhibition (Figure <xref ref-type="fig" rid="F1">1</xref>C). On the other hand, DUSP12 overexpression does not affect NF&#x003BA;B promoter activity in response to LPS stimulation (Figure <xref ref-type="supplementary-material" rid="SM1">S1</xref> in Supplementary Material). These evidences indicate that DUSP12 could have utilized its phosphatase domain to regulate MAPK signaling and MAPK-mediated responses. To further investigate the function of DUSP12 in macrophages, we generated stable overexpression of DUSP12 in RAW264.7 macrophage cell line. The overexpression of DUSP12 in selected clones were confirmed at both mRNA and protein levels (Figure <xref ref-type="fig" rid="F1">1</xref>D). Clone number 5 (D5) with the highest DUSP12 expression was selected for subsequent experiments to elucidate the role of this molecule in innate immunity.</p>
<fig id="F1" position="float">
<label>Figure 1</label>
<caption><p>Dual-specificity phosphatase 12 (DUSP12) interacted with mitogen-activated protein kinases (MAPKs) <italic>in vitro</italic> and inhibit AP-1 activation. <bold>(A)</bold> HEK293T cells were transfected with the pXJ40-Flag-DUSP12 or empty vectors. Flag-DUSP12 was pulled down using anti-Flag M2 resin. Flag-DUSP12 in the immunoprecipitates (IP) and in the whole cell lysates (WCL) were detected by anti-Flag Western blot analysis. Copurified extracellular signal-regulated protein kinase (ERK), Jun NH2-terminal kinase (JNK), and p38 in IP and total p38, JNK, and ERK in the WCL were detected using anti-P38, anti-JNK, and anti-ERK Western blot analysis. <bold>(B)</bold> RAW264.7 cells were stimulated with 100&#x02009;ng/ml LPS. MKP5 and DUSP12 mRNA expression was determined by quantitative real-time PCR (qRT-PCR). <bold>(C)</bold> Overexpression of DUSP12 in RAW264.7 cells inhibited AP-1 promoter activity. Point mutation in the phosphatase catalytic site abolished the inhibition. <bold>(D)</bold> DUSP12 mRNA and protein expression in DUSP12 stably transfected RAW264.7 cells. The data shown are representative of three independent experiments with similar results.</p></caption>
<graphic xlink:href="fimmu-08-01259-g001.tif"/>
</fig>
</sec>
<sec id="S3-2">
<title>DUSP12 Inhibits Proinflammatory Mediator Expression and p38/JNK Activation upon TLR4 Activation</title>
<p>Macrophages are known to secrete proinflammatory mediators including cytokines and chemokines upon activation of their pattern recognition receptors in the event of pathogen infection. To examine whether DUSP12 regulates the expression of these proinflammatory mediators in TLR4 signaling, we stimulated DUSP12 overexpressing (D5) and vector control RAW264.7 cells with LPS and found that mRNA expression of TNF-&#x003B1;, IL-6, IL-1&#x003B2;, and MCP-1 were highly induced in both D5 and control cells by LPS (Figure <xref ref-type="fig" rid="F2">2</xref>A). Moreover, there was a significant reduction in the expression of these proinflammatory mediators in D5 compared to the control cells. Interestingly, the expression of IL-10, a potent anti-inflammatory cytokine, was enhanced in D5 cells (Figure <xref ref-type="fig" rid="F2">2</xref>A). Similar phenotype was observed at protein levels for TNF-&#x003B1;, IL-6 and MCP-1, where the proteins detected were suppressed in D5 when compared to the control (Figure <xref ref-type="fig" rid="F2">2</xref>B). Together, these results indicate the inhibitory role of DUSP12 on the expression of proinflammatory mediators in macrophages in response to TLR activation.</p>
<fig id="F2" position="float">
<label>Figure 2</label>
<caption><p>Overexpression of dual-specificity phosphatase 12 (DUSP12) inhibited proinflammatory cytokine and chemokine production in response to toll-like receptor 4 (TLR4) activation by dephosphorylating p38 and Jun NH2-terminal kinase (JNK) mitogen-activated protein kinases (MAPKs). DUSP12 overexpressing and pcDNA control RAW264.7 cells were stimulated with 100&#x02009;ng/ml LPS. <bold>(A)</bold> Total mRNA was isolated after 3&#x02009;h LPS stimulation and subjected to quantitative real-time PCR (qRT-PCR) analysis of TNF-&#x003B1;, IL-6, IL-1&#x003B2;, MCP-1, and IL-10 level. <bold>(B)</bold> Culture supernatants were harvested 24&#x02009;h after LPS stimulation for enzyme-linked immunosorbent assay (ELISA) analysis of TNF-&#x003B1;, IL-6, and MCP-1 level. <bold>(C)</bold> Total proteins were harvested at different time-points for the detection of p38, JNK, and extracellular signal-regulated protein kinase (ERK) activation by Western blot. Relative p38, JNK, and ERK activation was measured by comparing phospho-MAPKs to total-MAPKs. The data shown are representative of two to three independent experiments with similar results. Data are presented as mean&#x02009;&#x000B1;&#x02009;SEM. &#x0002A;<italic>P</italic>-value&#x02009;&#x0003C;&#x02009;0.05; &#x0002A;&#x0002A;<italic>P</italic>-value&#x02009;&#x0003C;&#x02009;0.01.</p></caption>
<graphic xlink:href="fimmu-08-01259-g002.tif"/>
</fig>
<p>Mitogen-activated protein kinase pathway plays a crucial role in regulating the production of cytokines and chemokines during TLR activation in macrophages. To examine if the inhibition of proinflammatory cytokine production by DUSP12 is due to its regulation on MAPKs, the MAPKs activation profile in D5 and control cells were determined. In response to LPS stimulation, p38, JNK, and ERK were rapidly phosphorylated in both D5 and control cells but to different extents (Figure <xref ref-type="fig" rid="F2">2</xref>C). Overexpression of DUSP12 demonstrated significant reduction in p38 and JNK activation, while slight reduction in the activation of ERK was observed (Figure <xref ref-type="fig" rid="F2">2</xref>C). Together, the results demonstrated that DUSP12 inhibited proinflammatory cytokines and chemokines production in macrophages in response to LPS, possibly through inactivation of p38 and JNK.</p>
<p>To validate the function of DUSP12 in regulation of MAPK activation and cytokine expression in response to LPS, we utilized siRNA approach to knockdown the expression of DUSP12 in macrophages. We achieved about 50% knockdown of DUSP12 protein expression using a pool of siRNA targeting 4 regions of <italic>Dusp12</italic> gene (Figure <xref ref-type="supplementary-material" rid="SM2">S2</xref>A in Supplementary Material). Increased activation of p38, JNK, and ERK in response to LPS stimulation was observed in cells with DUSP12 knockdown (Figure <xref ref-type="supplementary-material" rid="SM2">S2</xref>B in Supplementary Material), which is associated with increased expression of proinflammatory cytokines including TNF-&#x003B1; and MCP-1 (Figure <xref ref-type="supplementary-material" rid="SM2">S2</xref>C in Supplementary Material). These results confirmed the negative regulation of MAPK activation and proinflammatory cytokine expression in macrophages by DUSP12.</p>
</sec>
<sec id="S3-3">
<title>DUSP12 Inhibits Proinflammatory Mediator Expression and p38 Activation upon Heat-Inactivated <italic>Mycobacterium</italic> Stimulation</title>
<p>Macrophages serve as a first line of defense during infection and thus, these pathogens evolved a myriad of strategies to evade macrophage-mediated inflammatory responses. It is vital to understand the regulation of these responses to better control bacterial infections. As such, DUSP12 function in regulating inflammatory responses is studied; where intracellular pathogens were used to stimulate macrophages to assess the proinflammatory cytokine production and MAPK activation profile. D5 and control cells were activated by heat-inactivated <italic>M. tuberculosis</italic> to examine macrophage inflammatory responses. Consistent with the role of DUSP12 in TLR4-mediated cytokine expression, overexpression of DUSP12 suppressed the expression of TNF-&#x003B1;, IL-1&#x003B2;, and MCP-1 (Figure <xref ref-type="supplementary-material" rid="SM3">S3</xref>A in Supplementary Material). This is also reflected in protein expression of TNF-&#x003B1; and MCP-1, where cytokine levels were significantly reduced in D5 cells as compared to vector control cells (Figure <xref ref-type="supplementary-material" rid="SM3">S3</xref>B in Supplementary Material).</p>
<p>Thereafter, <italic>M. bovis</italic> BCG was used as a surrogate for <italic>M. tuberculosis</italic> in the macrophage stimulation set-ups. D5 and control macrophages were infected at a multiplicity of eight and bacteria growth was assessed by the comparing the number of colony forming units (CFU) at various time-points postinfection. The CFU counts demonstrated that DUSP12 overexpression resulted in higher bacteria burden across all time-points, where the difference is significant in the later time-points as compared to the control cells (Figure <xref ref-type="fig" rid="F3">3</xref>A). The phenotype observed was correlated with MAPK activation profile and cytokine production. Western blot analysis demonstrated that overexpression of DUSP12 greatly inhibited p38 activation, but not the activation of JNK or ERK upon BCG infection (Figure <xref ref-type="fig" rid="F3">3</xref>B). The cytokine profile in D5 and control cells upon BCG stimulation revealed that expression of proinflammatory cytokines including TNF-&#x003B1; and MCP-1 was suppressed while anti-inflammatory cytokine, IL10 was upregulated (Figure <xref ref-type="fig" rid="F3">3</xref>C). Together, these results suggest that DUSP12 negatively regulates p38 activation and proinflammatory cytokine expression in macrophages upon the detection of Mycobacteria.</p>
<fig id="F3" position="float">
<label>Figure 3</label>
<caption><p>Overexpression of dual-specificity phosphatase 12 (DUSP12) inhibited proinflammatory cytokine and chemokine production in response to <italic>Mycobacteria</italic> infection by dephosphorylating p38 and Jun NH2-terminal kinase (JNK) mitogen-activated protein kinases (MAPKs). DUSP12 overexpressing and pcDNA control RAW264.7 cells were infected by <italic>Mycobacterium BCG</italic> at the bacteria-to-cell ratio 8:1 for 1&#x02009;h and extracellular <italic>Mycobacterium bovis</italic> BCG was removed. Infected macrophages were incubated in RPMI medium, containing 10% FBS for indicated periods of time. <bold>(A)</bold> Macrophages were lysed at various time-points using 0.1% Triton-X&#x02014;days 0, 1, 2, 5, and 7 to release intracellular <italic>M. bovis</italic> BCG and plated on Middlebrook&#x02019;s 7H11 agar medium. Colony forming unit (CFU) counts were enumerated after 16-day incubation and statistical analysis was conducted. Results are represented as the means&#x02009;&#x000B1;&#x02009;SDs of triplicates. Results are representative of two independent experiments. &#x0002A;<italic>P</italic>-value&#x02009;&#x0003C;&#x02009;0.05 and &#x0002A;&#x0002A;&#x0002A;<italic>P</italic>-value&#x02009;&#x0003C;&#x02009;0.001. <bold>(B)</bold> Total proteins were harvested at different time-points for the detection of p38, JNK, and extracellular signal-regulated protein kinase (ERK) activation by Western blot. Relative p38, JNK, and ERK activation was measured by comparing phospho-MAPKs to total-MAPKs. <bold>(C)</bold> Total mRNA was isolated 6&#x02009;h post-<italic>M. bovis</italic> BCG infection and subjected to quantitative real-time PCR (qRT-PCR) analysis of TNF-&#x003B1;, MCP-1, and IL-10 levels. The data shown are representative of three to four independent experiments with similar results.</p></caption>
<graphic xlink:href="fimmu-08-01259-g003.tif"/>
</fig>
</sec>
<sec id="S3-4">
<title>DUSP12 Inhibits Proinflammatory Mediator Expression and p38 Activation in Response to <italic>Listeria</italic> Infection</title>
<p>In the same manner, macrophages play a crucial role in immune responses against <italic>L. monocytogenes</italic>. To examine the regulatory role of DUSP12 in macrophages in response to <italic>Listeria</italic> infection, D5 and control cells were infected with <italic>L. monocytogenes</italic> at a MOI of 10 to assess bacterial load and cell survival. Similar to BCG infection profile, <italic>Listeria</italic> CFU counts was significantly higher in D5 cells as compared to the control at 6 and 12&#x02009;h postinfection (Figure <xref ref-type="fig" rid="F4">4</xref>A). The higher bacteria load had also resulted in greater cell death, where the difference between D5 and control is pronounced at the 48&#x02009;h postinfection (Figure <xref ref-type="supplementary-material" rid="SM4">S4</xref> in Supplementary Material). Furthermore, mRNA and protein expression of proinflammatory cytokines including TNF-&#x003B1;, IL-6, IL-1&#x003B2;, and IFN&#x003B2; were assessed. In control macrophages, the expression of these cytokines was greatly induced, while D5 cells showed significant suppression at 3 and 6&#x02009;h postinfection (Figure <xref ref-type="fig" rid="F4">4</xref>B). In addition, TNF-&#x003B1; protein expression was significantly attenuated in DUSP12 overexpressing cells compared to that in control cells upon <italic>Listeria</italic> infection (Figure <xref ref-type="fig" rid="F4">4</xref>C).</p>
<fig id="F4" position="float">
<label>Figure 4</label>
<caption><p>Overexpression of dual-specificity phosphatase 12 (DUSP12) impaired intracellular killing of <italic>Listeria monocytogenes</italic> in RAW264.7 cells. DUSP12 overexpressing and pcDNA control RAW264.7 cells were infected with <italic>L. monocytogenes</italic> at bacteria-to-cell ratio of 10:1 for 1&#x02009;h and extracellular Listeria were removed. Infected cells were continued to be incubated in RPMI medium with 5&#x02009;&#x003BC;g/ml gentamicin for indicated time periods. <bold>(A)</bold> Six and 12-h postinfection, cells were lysed to release intracellular <italic>L. monocytogenes</italic>. The released <italic>L. monocytogenes</italic> were subsequently cultured on BMI agar plates to count colony forming unit (CFU) after overnight incubation. <bold>(B)</bold> Total mRNA was isolated 3 and 6&#x02009;h post-<italic>Listeria</italic> infection and subjected to quantitative real-time PCR (qRT-PCR) analysis of TNF-&#x003B1;, IL-6, and IL-1&#x003B2; levels. <bold>(C)</bold> Culture supernatants were harvested 24&#x02009;h after <italic>Listeria</italic> stimulation for enzyme-linked immunosorbent assay (ELISA) analysis of TNF-&#x003B1;. <bold>(D)</bold> Total proteins were harvested at different time-points for the detection of p38, JNK, and extracellular signal-regulated protein kinase (ERK) activation by Western blot. Relative p38, JNK, and ERK activation was measured by comparing phospho-MAPKs to total-MAPKs. The data shown are representative of three to four independent experiments with similar results. Data are presented as mean&#x02009;&#x000B1;&#x02009;SEM. &#x0002A;<italic>P</italic>-value&#x02009;&#x0003C;&#x02009;0.05; &#x0002A;&#x0002A;<italic>P</italic>-value&#x02009;&#x0003C;&#x02009;0.01.</p></caption>
<graphic xlink:href="fimmu-08-01259-g004.tif"/>
</fig>
<p>Next, the activation of MAPKs in D5 and control cells in response to <italic>Listeria</italic> infection was examined. All three groups of MAPKs were activated in response to <italic>Listeria</italic> infection (Figure <xref ref-type="fig" rid="F4">4</xref>D). Clearly, overexpression of DUSP12 greatly inhibited p38 activation at all time points examined, compared to the control cells. In addition, JNK activation at 6&#x02009;h postinfection was reduced by DUSP12 overexpression, whereas ERK activation was comparable across all time-points between D5 and control cells (Figure <xref ref-type="fig" rid="F4">4</xref>D). Together, these results suggest that DUSP12 inhibits inflammatory mediator expression in macrophages during Listeria infection through attenuation of p38, and to a lesser extent, JNK activation.</p>
<p>Next, we selected another overexpressing clone (OXE), which has DUSP12 levels of approximately three to four times that of the control cells (Figure <xref ref-type="supplementary-material" rid="SM5">S5</xref>A in Supplementary Material), to verify the function of DUSP12 in macrophages in response to intracellular bacterial infection. Similar to D5 (which has eightfolds of DUSP12 overexpression, Figure <xref ref-type="fig" rid="F1">1</xref>D), OXE cells has reduced inflammatory cytokine expression (Figure <xref ref-type="supplementary-material" rid="SM5">S5</xref>B in Supplementary Material), associated with reduced MAPK activation but to a lesser extend as D5 (Figure <xref ref-type="supplementary-material" rid="SM5">S5</xref>C in Supplementary Material), and were less able to control BCG replication compared to control cells (Figure <xref ref-type="supplementary-material" rid="SM5">S5</xref>D in Supplementary Material). Together, these results confirm the inhibitory function of this protein on macrophage responses to intracellular bacterial infection by targeting MAPKs.</p>
</sec>
<sec id="S3-5">
<title>STAP2 Mediates the Interaction between DUSP12 and p38</title>
<p>Dual-specificity phosphatase 12 was able to interact with endogenous p38, ERK, and JNK (Figure <xref ref-type="fig" rid="F1">1</xref>A), with stronger binding to ERK and JNK than to p38. DUSP12 is an atypical DUSP that lacks the MAPK binding domain. Therefore, we postulated that an additional binding agent is recruited for the interaction between DUSP12 and MAPKs. The binding of DUSP12 to p38 is the weakest among the three MAPKs (Figure <xref ref-type="fig" rid="F1">1</xref>A), yet DUSP12 has the strongest inhibition toward the activation of p38 compared with that of JNK or ERK in macrophages upon TLR activation or intracellular bacterial infection. Therefore, we speculated that scaffold proteins might be present to mediate the interaction between DUSP12 and p38. Studies by Sekine et al. (<xref ref-type="bibr" rid="B28">28</xref>) demonstrated that signal-transducing adaptor protein-2 (STAP-2) in macrophages modulates cytokine production in TLR4 signaling pathway and thus, we studied the possible role of STAP proteins (STAP1 and STAP2) in facilitating DUSP12 and p38 interaction. Coimmunoprecipitation of the STAP proteins with DUSP12 revealed that STAP2, and not STAP1, interacted with DUSP12 (Figure <xref ref-type="fig" rid="F5">5</xref>A). In addition, in the presence of STAP2, DUSP12, and p38 interaction was enhanced (Figure <xref ref-type="fig" rid="F5">5</xref>B). These results suggest that STAP2 may function as a scaffold protein which mediates the interaction between DUSP12 and p38.</p>
<fig id="F5" position="float">
<label>Figure 5</label>
<caption><p>Signal transducing adaptor protein 2 (STAP2) enhanced interaction between dual-specificity phosphatase 12 (DUSP12) and p38 <italic>in vitro</italic>. <bold>(A)</bold> HEK293T cells were cotransfected with HA-DUSP12 and the pXJ40-Flag, pXJ40-Flag-STAP1, or pXJ40-Flag-STAP2 vectors. Flag-STAP1/2 was pulled down using anti-Flag M2 resin. Flag-STAP1 and Flag-STAP2 in the immunoprecipitates (IPs) and in the whole cell lysates (WCL) were detected by anti-Flag Western blot analysis. Copurified HA-DUSP12 in the IP and in the WCL was detected using anti-HA Western blot analysis. <bold>(B)</bold> HEK293T cells were cotransfected with HA-STAP2 and the pXJ40-Flag or pXJ40-Flag-DUSP12 vectors. Flag-DUSP12 was pulled down using anti-Flag M2 resin. Flag-DUSP12 in the IP and in the WCL were detected by anti-Flag Western blot analysis. Copurified p38 and HA-STAP2 in the IP and in the WCL were detected using anti-p38 and anti-HA Western blot analysis. <bold>(C)</bold> Schematic describing various STAP2 deletion constructs&#x02014;full-length STAP2, &#x00394;PH, &#x00394;SH2, and &#x00394;C. <bold>(D)</bold> HEK293T cells were cotransfected with HA-DUSP12 and the pXJ40-Flag, pXJ40-Flag-STAP2 or pXJ40-Flag-&#x00394;PH, pXJ40-Flag-&#x00394;SH2, and pXJ40-Flag-&#x00394;C vectors. Flag-STAP constructs were pulled down using anti-Flag M2 resin. Flag-STAP constructs in the IP and in the WCL were detected by anti-Flag Western blot analysis. Copurified HA-DUSP12 in the IP and in the WCL was detected using anti-HA Western blot analysis. Relative DUSP12-STAP2 interaction is measured by quantification of HA-DUSP12 in the immunoprecipitate with respect to the levels of FLAG-STAP2 constructs in the immunoprecipitate. <bold>(E)</bold> HEK293T cells were cotransfected with the pXJ40-Flag, pXJ40-Flag-STAP2 or pXJ40-Flag-&#x00394;PH, pXJ40-Flag-&#x00394;SH2, and pXJ40-Flag-&#x00394;C vectors. Flag-STAP2 constructs were pulled down using anti-Flag M2 resin. Flag-STAP2 constructs in the IP and in the WCL were detected by anti-Flag Western blot analysis. Copurified p38 were detected using anti-p38 Western blot analysis. Relative p38-STAP2 interaction is measured by quantification of p38 in the immunoprecipitate with respect to the levels of FLAG-STAP2 constructs in the immunoprecipitate. The data shown are representative of two to three independent experiments with similar results.</p></caption>
<graphic xlink:href="fimmu-08-01259-g005.tif"/>
</fig>
<p>Signal transducing adaptor protein 2 contains an N-terminal pleckstrin homology (PH) domain, a central Src homology 2-like (SH2) domain, and a proline-rich YXXQ motif in the C-terminal. Several studies demonstrated that the SH2 domain is important for binding to other proteins including FAK, IKKs, MyD88, and STAT3/5 (<xref ref-type="bibr" rid="B28">28</xref>&#x02013;<xref ref-type="bibr" rid="B30">30</xref>). Hence, several STAP2 constructs were generated (Figure <xref ref-type="fig" rid="F5">5</xref>C) and the binding potential of these proteins to DUSP12 and p38 were examined. We found that deletion of the SH2 domain (&#x00394;SH2) and C-terminal domain (&#x00394;C) of STAP2 did not affect its interaction with DUSP12, whereas deletion of the PH domain (&#x00394;PH) led to much weaker interaction with DUSP12 (Figure <xref ref-type="fig" rid="F5">5</xref>D). Similarly, &#x00394;SH2 mutant and &#x00394;C mutant of STAP2 were able to interact with p38, whereas &#x00394;PH mutant failed to interact with p38 (Figure <xref ref-type="fig" rid="F5">5</xref>E). Together, these results suggest that the PH domain of STAP2 is required for its interaction with both DUSP12 and p38.</p>
<p>Dual-specificity phosphatase 12 contains an N-terminal catalytic domain, a C-terminal zinc finger domain, and an ALDH site (Figure <xref ref-type="fig" rid="F6">6</xref>A). To test the function of these domains of DUSP12 in its interaction with STAP2, we generated several truncated DUSP12 constructs (Figure <xref ref-type="fig" rid="F6">6</xref>A) and were used to perform immunoprecipitation with STAP2. We found that deletion of the N-terminal catalytic domain did not affect it interaction with STAP2, whereas deletion of its C-terminal domain, including the zinc finger domain and the ALDH site resulted in weakened interaction with STAP2 (Figure <xref ref-type="fig" rid="F6">6</xref>B). This suggests that the DUSP12 C-terminal domain including the zinc finger domain and the ALDH site is required for its interaction with STAP2. Furthermore, the lack of C-terminal domain in DUSP12 impaired its interaction with ERK, JNK, and p38 (Figure <xref ref-type="fig" rid="F6">6</xref>C). Particularly, the interaction between DUSP12 and p38 was completely lost, suggesting that the C-terminal domain of DUSP12 is required for its interaction with p38, likely <italic>via</italic> STAP2.</p>
<fig id="F6" position="float">
<label>Figure 6</label>
<caption><p>Pleckstrin homology (PH) domain of signal-transducing adaptor protein-2 (STAP2) is responsible for its interaction with p38 and dual-specificity phosphatase 12 (DUSP12) <italic>in vitro</italic>. <bold>(A)</bold> Schematic describing various DUSP12 deletion constructs. <bold>(B)</bold> HEK293T cells were transfected with HA-STAP2 and the pXJ40-Flag, pXJ40-Flag-DUSP12 or pXJ40-Flag-DUSP12-&#x00394;CT1, pXJ40-Flag-DUSP12-&#x00394;CT2, pXJ40-Flag-DUSP12-&#x00394;CT3, or pXJ40-Flag-DUSP12-&#x00394;NT vectors. Flag-tagged STAP2 mutants were pulled down using anti-Flag M2 resin. Flag-tagged STAP2 mutants in the immunoprecipitates (IP) and in the whole cell lysates (WCL) were detected by anti-Flag Western blot analysis. Relative STAP2-DUSP12 interaction is measured by quantification of HA-STAP2 in the immunoprecipitate with respect to the levels of FLAG-DUSP12 constructs in the immunoprecipitate. <bold>(C)</bold> HEK293T cells were cotransfected with pXJ40-Flag, pXJ40-Flag-DUSP12-&#x00394;CT1, or pXJ40-Flag-DUSP12-&#x00394;CT2 vectors. Flag-tagged DUSP12 mutants were pulled down using anti-Flag M2 resin. FLAG-STAP2 mutants in the IP and in the WCL were detected by anti-Flag Western blot analysis. Copurified extracellular signal-regulated protein kinase (ERK), p38, and JNK MAPKs in the IP and in the WCL were detected using anti-ERK, anti-JNK, and anti-p38 Western blot analysis. The data shown are representative of two to three independent experiments with similar results.</p></caption>
<graphic xlink:href="fimmu-08-01259-g006.tif"/>
</fig>
</sec>
</sec>
<sec id="S4" sec-type="discussion">
<title>Discussion</title>
<p>Mitogen-activated protein kinases control major cellular activities such as cell differentiation, stress responses, apoptosis, and immune defenses (<xref ref-type="bibr" rid="B31">31</xref>, <xref ref-type="bibr" rid="B32">32</xref>) and thus it is of high importance to tightly regulate MAPK activity. DUSP plays a critical role in regulating these cascades, thereby keeping cellular activities in check. There are 25 DUSPs encoded by the human genome which comprises of 15 atypical DUSPs (<xref ref-type="bibr" rid="B14">14</xref>). Despite the abundance of atypical DUSPs, the biological functions of DUSPs are much less understood. In this study, we demonstrated that DUSP12, an atypical DUSP, acts as a p38 and JNK phosphatase in macrophages, thereby regulating macrophage responses to intracellular bacterial infection.</p>
<p>We first examined the expression of DUSP12 in macrophages in response to TLR activation and found that, unlike DUSP1 (MKP1) and DUSP10 (MKP5) which are rapidly induced in response to TLR activation (<xref ref-type="bibr" rid="B12">12</xref>, <xref ref-type="bibr" rid="B27">27</xref>), the expression of DUSP12 was not as highly modulated in RAW264.7 cells (Figure <xref ref-type="fig" rid="F1">1</xref>B), suggesting that the expression of this gene is more tightly regulated than DUSP1 or DUSP10. Nevertheless, similar to DUSP10 (<xref ref-type="bibr" rid="B27">27</xref>), overexpression of DUSP12 inhibited the activation of AP-1, a transcription factor known be a downstream target of TLR4 signaling pathway and a major target of MAPKs, upon TLR4 activation (Figure <xref ref-type="fig" rid="F1">1</xref>C). Furthermore, the conserved phosphatase domain in DUSP12 is found to be crucial for its function in regulating AP-1 activation since point mutation in the enzymatic site abolished its inhibition of AP-1 activation. We further establish that DUSP12 can interact with the three major MAPKs groups&#x02014;ERK, JNK, and p38, despite the lack of the MKB domain (Figure <xref ref-type="fig" rid="F1">1</xref>A). In addition, overexpression of DUSP12 in macrophages suppressed p38 and JNK activation in response to TLR4 stimulation or intracellular bacterial infection (Figures <xref ref-type="fig" rid="F2">2</xref>C, <xref ref-type="fig" rid="F3">3</xref>B and <xref ref-type="fig" rid="F4">4</xref>C). Together, these observations suggest that DUSP12 is a MAPK phosphatase and regulates MAPK-mediated responses, of which is dependent on its phosphatase activity.</p>
<p>Interestingly, immunoprecipitation data showed that the interaction between DUSP12 and p38 is the weakest as compared to JNK or ERK (Figure <xref ref-type="fig" rid="F1">1</xref>A), but it is apparent that DUSP12 mainly suppresses the activation of p38 in macrophages during intracellular bacterial infection (Figures <xref ref-type="fig" rid="F3">3</xref>B and <xref ref-type="fig" rid="F4">4</xref>D). This suggests that the presence of regulatory mechanism, which may mediate the interaction between DUSP12 and p38. It is well known that the formation of signaling complexes is crucial for the specificity of signal transduction cascades such as MAPK pathways. These complexes may be formed by direct docking interaction between corresponding partners in the signal cascade, or by assembly of signaling and regulatory components on scaffold proteins which bring their binding partners to specific substrates (<xref ref-type="bibr" rid="B10">10</xref>). DUSP can interact with MAPK either by docking or scaffolding. Classical DUSPs share a common structure comprising of a C-terminal catalytic domain and an N-terminal KBD, which contains conserved KIMs. They can recognize specific MAPK targets though interaction with a common docking (CD) site within their structure. Previous studies have shown that the KBD of DUSP10 binds p38&#x003B1; in a bipartite manner, in which two distinct helical regions of KBD engage the p38&#x003B1; docking site (<xref ref-type="bibr" rid="B33">33</xref>). However, atypical DUSP12, lacks the conserved KBD domain for docking with MAPKs. Therefore, alternative interactions may explain the specific inhibition of p38 and JNK activation. We propose the involvement of scaffold proteins which direct DUSP12 to its target MAPKs. To this end, we identified STAP2 as a scaffold protein mediating the interaction between DUSP12 and p38. We found that DUSP12 specifically interacts with STAP2 but not STAP1. In the presence of STAP2, p38 binding to DUSP12 is enhanced (Figures <xref ref-type="fig" rid="F5">5</xref>A,B), indicating STAP2 might recruit DUSP12 to p38. STAP2 is constitutively expressed in macrophages, and STAP2 deficient macrophages showed significantly impairment of TLR4-mediated cytokine production (<xref ref-type="bibr" rid="B28">28</xref>). Our results support previous literature, where STAP2 has a regulatory role in cellular signaling of innate and adaptive immune systems (<xref ref-type="bibr" rid="B34">34</xref>). We further identified that the PH domain of STAP2 is required for its interaction with DUSP12 and p38, whereas the C-terminal region of DUSP12 is important for its interaction with STAP2 and p38 (Figure <xref ref-type="fig" rid="F5">5</xref>). Despite these findings, the exact mechanism of STAP2&#x02013;DUSP12 interaction with p38 is unclear. One possibility is that DUSP12 is constantly associated with STAP2, where the bound state restricts DUSP12 activity. Upon signaling from PRRs, DUSP12 may dissociate from STAP2 and form a complex with p38. Alternatively, cellular localization or specific extracellular stimuli may trigger the recruitment of DUSP12 to STAP2, which then form a complex with p38 to ensure controlled p38 activation.</p>
<p>Dual-specificity phosphatase 12 overexpressing RAW264.7 cells were generated to further explore the functions of the MAPK regulator. We found that the production of proinflammatory cytokines, TNF-&#x003B1;, IL-6 and MCP-1, were impaired in the DUSP12 overexpressing cells, associated with reduced activations of p38 and JNK, but not ERK activation in response to LPS stimulation, BCG, and <italic>Listeria</italic> infection (Figures <xref ref-type="fig" rid="F2">2</xref>&#x02013;<xref ref-type="fig" rid="F4">4</xref>).</p>
<p>Inflammatory activation of macrophages has been shown to be essential for defense against intracellular pathogens including <italic>M. tuberculosis and L. monogeneses</italic> (<xref ref-type="bibr" rid="B35">35</xref>). <italic>M. tuberculosis</italic> is the infectious agent of the fatal disease&#x02014;tuberculosis. The bacilli enter the host <italic>via</italic> the respiratory tract and are met with alveolar macrophages. Current literature has reported various immune evasion techniques <italic>M. tuberculosis</italic> has employed and one of which is modulation of host cell signaling. Previous studies have described that activation of ERK and p38 pathways lead to the production of mycobacteria-induced TNF-&#x003B1;, while ERK activation alone results in mycobacteria induced MCP-1 (<xref ref-type="bibr" rid="B36">36</xref>, <xref ref-type="bibr" rid="B37">37</xref>). As described in Figure <xref ref-type="fig" rid="F3">3</xref>B, the suppression of MAPK might have reduced the expression of the mycobacteria-induced TNF-&#x003B1; and MCP-1. However, contrary to the study by Song et al. (<xref ref-type="bibr" rid="B36">36</xref>), we observed that the p38 suppression by DUSP12 led to enhanced anti-inflammatory IL10 production in the mycobacteria stimulation model (Figure <xref ref-type="fig" rid="F3">3</xref>C). Our findings support that modulation of MAPK pathways leads to the suppression of antimycobacterial cytokines whilst enhancing the production of macrophage inhibitory cytokines (<xref ref-type="bibr" rid="B38">38</xref>). DUSP12 may facilitate <italic>Mycobacteria</italic> survival in host macrophages where we observed increase CFU counts in the DUSP12 overexpressing strain (Figure <xref ref-type="fig" rid="F3">3</xref>). With widespread incidences of multidrug resistant tuberculosis and limitations in novel tubercular drug discovery, DUSP12 may potentially serve as a target for drug development. As the mechanism to which DUSP12 regulates immune responses is unclear, we postulate that DUSP12 inhibition may favor inflammatory responses and thus enhancing bactericidal mechanisms. Akin to Mycobacteria, macrophages serve as a primary host for <italic>L. monocytogenes</italic>. Monocytes and macrophages play a key role in defense against <italic>L. monocytogenes</italic> infection (<xref ref-type="bibr" rid="B35">35</xref>), where TLR signaling is essential for protection. Monocyte- and macrophage-specific deficiency of TLR signaling resulted in susceptibility to <italic>L. monocytogenes</italic> infection in mice models, which are associated with defective production of proinflammatory cytokines, including IL-12 and TNF-&#x003B1; (<xref ref-type="bibr" rid="B35">35</xref>). These studies highlighted the importance of proper regulation of TLR signaling in innate immune cells such as macrophages in intracellular pathogen infection. In this study, we detected significant induction and secretion of TNF-&#x003B1; in macrophages in response to <italic>Listeria</italic> infection. Overexpression of DUSP12 impaired the expression of TNF-&#x003B1; by selectively inhibiting p38 and JNK (Figure <xref ref-type="fig" rid="F4">4</xref>). This demonstrates a negative role of DUSP12 in regulating macrophage responses against <italic>Listeria</italic> infection. Furthermore, we also demonstrated that overexpression of DUSP12 impaired the macrophage bactericidal mechanisms toward intracellular <italic>Listeria</italic>. Failure to control the infection leads to reduced cellular survival (Figure <xref ref-type="supplementary-material" rid="SM2">S2</xref> in Supplementary Material). Together, our study suggests that DUSP12 plays an essential role in controlling intracellular bacteria replication through the regulation of MAPKs.</p>
<p>In summary, this study demonstrates that DUSP12 is a p38 and JNK phosphatase, where modulation in MAPKs activation leads to impairment of proinflammatory cytokine and chemokine production in macrophages upon TLR activation or pathogen infection. In addition, this study provides a model where atypical DUSPs, like DUSP12, regulate the activation of MAPKs <italic>via</italic> scaffold proteins to regulate immune responses despite the lack of a MAPK binding domain.</p>
</sec>
<sec id="S5" sec-type="author-contributor">
<title>Author Contributions</title>
<p>SC, HJ, SA and YZ designed the experiments and interpreted the data. CS, HJ and YZ wrote the manuscript. SC, HJ, SJ, CP and MW performed the study, data analysis and statistical evaluation.</p>
</sec>
<sec id="S6">
<title>Conflict of Interest Statement</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
</body>
<back>
<ack>
<p>This study was supported by grants from the National University Health System of Singapore (T1&#x02014;October 12, 2014, and T1&#x02014;September 10, 2015).</p>
</ack>
<sec id="S7" sec-type="supplementary-material">
<title>Supplementary Material</title>
<p>The Supplementary Material for this article can be found online at <uri xlink:href="http://journal.frontiersin.org/article/10.3389/fimmu.2017.01259/full&#x00023;supplementary-material">http://journal.frontiersin.org/article/10.3389/fimmu.2017.01259/full&#x00023;supplementary-material</uri>.</p>
<supplementary-material xlink:href="image_1.jpeg" id="SM1" mimetype="applicationn/jpeg" xmlns:xlink="http://www.w3.org/1999/xlink"><label>Figure S1</label><caption><p>DUSP12 does not inhibit NF<sub>k</sub>B activity. Overexpression of DUSP12 in RAW264.7 cells did not inhibit NF<sub>k</sub>B promoter activity. Point mutation in the phosphatase catalytic site showed a similar effect as the DUSP12 overexpressing and pcDNA control upon stimulation with 100&#x02009;ng/ml LPS.</p></caption></supplementary-material>
<supplementary-material xlink:href="image_2.jpeg" id="SM2" mimetype="applicationn/jpeg" xmlns:xlink="http://www.w3.org/1999/xlink"><label>Figure S2</label><caption><p>Knockdown of DUSP12 expression resulted in increased MAPK activation and increased expression of proinflammatory cytokines in response to LPS stimulation. <bold>(A)</bold> Total protein was harvested for the detection of DUSP12 protein expression in macrophages treated with 25 and 100&#x02009;nM of NTC and 25, 50, and 100&#x02009;nM of si-DUSP12. <bold>(B)</bold> RAW264.7 cells with control or si-DUSP12 treatment were stimulated with LPS. Total proteins were harvested at different time-points for the detection of p38, JNK and ERK activation by western-blot. Relative p38, JNK and ERK activation was measured by comparing phospho-MAPKs to actin. <bold>(C)</bold> Total mRNA was isolated 3-h post-LPS stimulation and subjected to quantitative qRT-PCR analysis of TNF-&#x003B1; and MCP-1. Results are represented as the means&#x02009;&#x000B1;&#x02009;SDs of duplicates. Results are representative of two independent experiments. &#x0002A;<italic>P</italic>-value&#x02009;&#x0003C;&#x02009;0.05.</p></caption></supplementary-material>
<supplementary-material xlink:href="image_3.jpeg" id="SM3" mimetype="applicationn/jpeg" xmlns:xlink="http://www.w3.org/1999/xlink"><label>Figure S3</label><caption><p>Overexpression of DUSP12 inhibited proinflammatory cytokine and chemokine production in response to <italic>Mycobacteria</italic> stimulation. DUSP12 overexpressing and pcDNA control RAW264.7 cells were stimulated with heat-inactivated <italic>Mycobacterium tuberculosis</italic> at the bacteria-to-cell ratio 8:1. <bold>(A)</bold> Total mRNA was isolated 3 and 6&#x02009;h postinfection and subjected to quantitative qRT-PCR analysis of TNF-&#x003B1;, IL-1&#x003B2;, and MCP-1 levels. <bold>(B)</bold> Culture supernatants were harvested 24&#x02009;h after heat-inactivated TB stimulation for ELISA analysis of TNF-&#x003B1; and MCP-1. Data are presented as mean&#x02009;&#x000B1;&#x02009;SEM.</p></caption></supplementary-material>
<supplementary-material xlink:href="image_4.jpeg" id="SM4" mimetype="applicationn/jpeg" xmlns:xlink="http://www.w3.org/1999/xlink"><label>Figure S4</label><caption><p>Cell survival after <italic>L. monocytogenes</italic> infection. DUSP12 overexpressing and pcDNA control RAW264.7 cells were infected with <italic>L. monocytogenes</italic> at bacteria-to-cell ratio of 10:1 for 1&#x02009;h and extracellular Listeria were removed. Infected cells were continued to be incubated in RPMI medium with 5&#x02009;&#x003BC;g/ml gentamicin for 24 or 48&#x02009;h. Cell proliferation was determined by crystal violet staining. Absorbance was measured at 590&#x02009;nm. Percentage of cell survival was obtained by comparing absorbance of infected to that of uninfected cells.</p></caption></supplementary-material>
<supplementary-material xlink:href="image_5.jpeg" id="SM5" mimetype="applicationn/jpeg" xmlns:xlink="http://www.w3.org/1999/xlink"><label>Figure S5</label><caption><p>Threefold overexpression of DUSP12 demonstrates similar inhibition of proinflammatory cytokine and chemokine production in response to <italic>M. bovis</italic> BCG infection by dephosphorylating p38 and JNK MAPKs. <bold>(A)</bold> DUSP12 overexpressing clone, OXE demonstrates a 3-fold overexpression as compared to control vector. <bold>(B)</bold> OXE and pcDNA control RAW264.7 cells were infected by <italic>Mycobacterium BCG</italic> at the bacteria-to-cell ratio 8:1. Total proteins were harvested at different time-points for the detection of p38, JNK and ERK activation by western-blot. Relative p38, JNK and ERK activation was measured by comparing phospho-MAPKs to total-MAPKs. <bold>(C)</bold> Total mRNA was isolated 1&#x02009;h post-<italic>M. bovis</italic> BCG infection and subjected to quantitative qRT-PCR analysis of TNF-&#x003B1; and MCP-1. <bold>(D)</bold> OXE and pcDNA control RAW264.7 cells were infected by <italic>Mycobacterium BCG</italic> at the bacteria-to-cell ratio 8:1 for 1&#x02009;h and extracellular <italic>M. bovis</italic> BCG was removed. Infected macrophages were incubated in RPMI medium, containing 10% FBS for indicated periods of time. Macrophages were lysed at various time-points using 0.1% Triton-X&#x02014;days 0, 1, 2, 5, and 7 to release intracellular <italic>M. bovis</italic> BCG and plated on Middlebrook&#x02019;s 7H11 agar medium. CFU counts were enumerated after 16&#x02009;days of incubation and statistical analysis was conducted. Results are represented as the means&#x02009;&#x000B1;&#x02009;SDs of triplicates. Results are representative of two independent experiments. &#x0002A;<italic>P</italic>-value&#x02009;&#x0003C;&#x02009;0.05 and &#x0002A;&#x0002A;&#x0002A;<italic>P</italic>-value&#x02009;&#x0003C;&#x02009;0.001.</p></caption></supplementary-material>
</sec>
<ref-list>
<title>References</title>
<ref id="B1"><label>1</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Albiger</surname> <given-names>B</given-names></name> <name><surname>Dahlberg</surname> <given-names>S</given-names></name> <name><surname>Henriques-Normark</surname> <given-names>B</given-names></name> <name><surname>Normark</surname> <given-names>S</given-names></name></person-group>. <article-title>Role of the innate immune system in host defence against bacterial infections: focus on the toll-like receptors</article-title>. <source>J Intern Med</source> (<year>2007</year>) <volume>261</volume>(<issue>6</issue>):<fpage>511</fpage>&#x02013;<lpage>28</lpage>.<pub-id pub-id-type="doi">10.1111/j.1365-2796.2007.01821.x</pub-id><pub-id pub-id-type="pmid">17547708</pub-id></citation></ref>
<ref id="B2"><label>2</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rock</surname> <given-names>FL</given-names></name> <name><surname>Hardiman</surname> <given-names>G</given-names></name> <name><surname>Timans</surname> <given-names>JC</given-names></name> <name><surname>Kastelein</surname> <given-names>RA</given-names></name> <name><surname>Bazan</surname> <given-names>JF</given-names></name></person-group>. <article-title>A family of human receptors structurally related to <italic>Drosophila</italic> toll</article-title>. <source>Proc Natl Acad Sci U S A</source> (<year>1998</year>) <volume>95</volume>(<issue>2</issue>):<fpage>588</fpage>&#x02013;<lpage>93</lpage>.<pub-id pub-id-type="doi">10.1073/pnas.95.2.588</pub-id><pub-id pub-id-type="pmid">9435236</pub-id></citation></ref>
<ref id="B3"><label>3</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Takeuchi</surname> <given-names>O</given-names></name> <name><surname>Hoshino</surname> <given-names>K</given-names></name> <name><surname>Kawai</surname> <given-names>T</given-names></name> <name><surname>Sanjo</surname> <given-names>H</given-names></name> <name><surname>Takada</surname> <given-names>H</given-names></name> <name><surname>Ogawa</surname> <given-names>T</given-names></name> <etal/></person-group> <article-title>Differential roles of TLR2 and TLR4 in recognition of Gram-negative and Gram-positive bacterial cell wall components</article-title>. <source>Immunity</source> (<year>1999</year>) <volume>11</volume>(<issue>4</issue>):<fpage>443</fpage>&#x02013;<lpage>51</lpage>.<pub-id pub-id-type="doi">10.1016/S1074-7613(00)80119-3</pub-id><pub-id pub-id-type="pmid">10549626</pub-id></citation></ref>
<ref id="B4"><label>4</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hayashi</surname> <given-names>F</given-names></name> <name><surname>Smith</surname> <given-names>KD</given-names></name> <name><surname>Ozinsky</surname> <given-names>A</given-names></name> <name><surname>Hawn</surname> <given-names>TR</given-names></name> <name><surname>Eugene</surname> <given-names>CY</given-names></name> <name><surname>Goodlett</surname> <given-names>DR</given-names></name> <etal/></person-group> <article-title>The innate immune response to bacterial flagellin is mediated by toll-like receptor 5</article-title>. <source>Nature</source> (<year>2001</year>) <volume>410</volume>(<issue>6832</issue>):<fpage>1099</fpage>&#x02013;<lpage>103</lpage>.<pub-id pub-id-type="doi">10.1038/35074106</pub-id><pub-id pub-id-type="pmid">11323673</pub-id></citation></ref>
<ref id="B5"><label>5</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hemmi</surname> <given-names>H</given-names></name> <name><surname>Takeuchi</surname> <given-names>O</given-names></name> <name><surname>Kawai</surname> <given-names>T</given-names></name> <name><surname>Kaisho</surname> <given-names>T</given-names></name> <name><surname>Sato</surname> <given-names>S</given-names></name> <name><surname>Sanjo</surname> <given-names>H</given-names></name> <etal/></person-group> <article-title>A toll-like receptor recognizes bacterial DNA</article-title>. <source>Nature</source> (<year>2000</year>) <volume>408</volume>(<issue>6813</issue>):<fpage>740</fpage>&#x02013;<lpage>5</lpage>.<pub-id pub-id-type="doi">10.1038/35047123</pub-id><pub-id pub-id-type="pmid">11130078</pub-id></citation></ref>
<ref id="B6"><label>6</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cristofaro</surname> <given-names>P</given-names></name> <name><surname>Opal</surname> <given-names>SM</given-names></name></person-group>. <article-title>Role of toll-like receptors in infection and immunity</article-title>. <source>Drugs</source> (<year>2006</year>) <volume>66</volume>(<issue>1</issue>):<fpage>15</fpage>&#x02013;<lpage>29</lpage>.<pub-id pub-id-type="doi">10.2165/00003495-200666010-00002</pub-id></citation></ref>
<ref id="B7"><label>7</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sato</surname> <given-names>S</given-names></name> <name><surname>Sanjo</surname> <given-names>H</given-names></name> <name><surname>Takeda</surname> <given-names>K</given-names></name> <name><surname>Ninomiya-Tsuji</surname> <given-names>J</given-names></name> <name><surname>Yamamoto</surname> <given-names>M</given-names></name> <name><surname>Kawai</surname> <given-names>T</given-names></name> <etal/></person-group> <article-title>Essential function for the kinase TAK1 in innate and adaptive immune responses</article-title>. <source>Nat Immunol</source> (<year>2005</year>) <volume>6</volume>(<issue>11</issue>):<fpage>1087</fpage>&#x02013;<lpage>95</lpage>.<pub-id pub-id-type="doi">10.1038/ni1255</pub-id><pub-id pub-id-type="pmid">16186825</pub-id></citation></ref>
<ref id="B8"><label>8</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Beutler</surname> <given-names>B</given-names></name> <name><surname>Hoebe</surname> <given-names>K</given-names></name> <name><surname>Du</surname> <given-names>X</given-names></name> <name><surname>Ulevitch</surname> <given-names>R</given-names></name></person-group>. <article-title>How we detect microbes and respond to them: the toll-like receptors and their transducers</article-title>. <source>J Leukoc Biol</source> (<year>2003</year>) <volume>74</volume>(<issue>4</issue>):<fpage>479</fpage>&#x02013;<lpage>85</lpage>.<pub-id pub-id-type="doi">10.1189/jlb.0203082</pub-id><pub-id pub-id-type="pmid">12960260</pub-id></citation></ref>
<ref id="B9"><label>9</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dumitru</surname> <given-names>CD</given-names></name> <name><surname>Ceci</surname> <given-names>JD</given-names></name> <name><surname>Tsatsanis</surname> <given-names>C</given-names></name> <name><surname>Kontoyiannis</surname> <given-names>D</given-names></name> <name><surname>Stamatakis</surname> <given-names>K</given-names></name> <name><surname>Lin</surname> <given-names>J-H</given-names></name> <etal/></person-group> <article-title>TNF-&#x003B1; induction by LPS is regulated posttranscriptionally via a Tpl2/ERK-dependent pathway</article-title>. <source>Cell</source> (<year>2000</year>) <volume>103</volume>(<issue>7</issue>):<fpage>1071</fpage>&#x02013;<lpage>83</lpage>.<pub-id pub-id-type="doi">10.1016/S0092-8674(00)00210-5</pub-id></citation></ref>
<ref id="B10"><label>10</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname> <given-names>Y</given-names></name> <name><surname>Dong</surname> <given-names>C</given-names></name></person-group>. <article-title>Regulatory mechanisms of mitogen-activated kinase signaling</article-title>. <source>Cell Mol Life Sci</source> (<year>2007</year>) <volume>64</volume>(<issue>21</issue>):<fpage>2771</fpage>&#x02013;<lpage>89</lpage>.<pub-id pub-id-type="doi">10.1007/s00018-007-7012-3</pub-id><pub-id pub-id-type="pmid">17726577</pub-id></citation></ref>
<ref id="B11"><label>11</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Esnault</surname> <given-names>S</given-names></name> <name><surname>Malter</surname> <given-names>JS</given-names></name></person-group>. <article-title>Extracellular signal-regulated kinase mediates granulocyte-macrophage colony-stimulating factor messenger RNA stabilization in tumor necrosis factor-&#x003B1; plus fibronectin-activated peripheral blood eosinophils</article-title>. <source>Blood</source> (<year>2002</year>) <volume>99</volume>(<issue>11</issue>):<fpage>4048</fpage>&#x02013;<lpage>52</lpage>.<pub-id pub-id-type="doi">10.1182/blood.V99.11.4048</pub-id></citation></ref>
<ref id="B12"><label>12</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hammer</surname> <given-names>M</given-names></name> <name><surname>Mages</surname> <given-names>J</given-names></name> <name><surname>Dietrich</surname> <given-names>H</given-names></name> <name><surname>Servatius</surname> <given-names>A</given-names></name> <name><surname>Howells</surname> <given-names>N</given-names></name> <name><surname>Cato</surname> <given-names>AC</given-names></name> <etal/></person-group> <article-title>Dual specificity phosphatase 1 (DUSP1) regulates a subset of LPS-induced genes and protects mice from lethal endotoxin shock</article-title>. <source>J Exp Med</source> (<year>2006</year>) <volume>203</volume>(<issue>1</issue>):<fpage>15</fpage>&#x02013;<lpage>20</lpage>.<pub-id pub-id-type="doi">10.1084/jem.20051753</pub-id><pub-id pub-id-type="pmid">16380512</pub-id></citation></ref>
<ref id="B13"><label>13</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cornell</surname> <given-names>TT</given-names></name> <name><surname>Rodenhouse</surname> <given-names>P</given-names></name> <name><surname>Cai</surname> <given-names>Q</given-names></name> <name><surname>Sun</surname> <given-names>L</given-names></name> <name><surname>Shanley</surname> <given-names>TP</given-names></name></person-group>. <article-title>Mitogen-activated protein kinase phosphatase 2 regulates the inflammatory response in sepsis</article-title>. <source>Infect Immun</source> (<year>2010</year>) <volume>78</volume>(<issue>6</issue>):<fpage>2868</fpage>&#x02013;<lpage>76</lpage>.<pub-id pub-id-type="doi">10.1128/IAI.00018-10</pub-id><pub-id pub-id-type="pmid">20351138</pub-id></citation></ref>
<ref id="B14"><label>14</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname> <given-names>C-Y</given-names></name> <name><surname>Tan</surname> <given-names>T-H</given-names></name></person-group>. <article-title>DUSPs, to MAP kinases and beyond</article-title>. <source>Cell Biosci</source> (<year>2012</year>) <volume>2</volume>(<issue>1</issue>):<fpage>24</fpage>.<pub-id pub-id-type="doi">10.1186/2045-3701-2-24</pub-id><pub-id pub-id-type="pmid">22769588</pub-id></citation></ref>
<ref id="B15"><label>15</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Keyse</surname> <given-names>SM</given-names></name> <name><surname>Ginsburg</surname> <given-names>M</given-names></name></person-group>. <article-title>Amino acid sequence similarity between CL100, a dual-specificity MAP kinase phosphatase and CDC25</article-title>. <source>Trends Biochem Sci</source> (<year>1993</year>) <volume>18</volume>(<issue>10</issue>):<fpage>377</fpage>&#x02013;<lpage>8</lpage>.<pub-id pub-id-type="doi">10.1016/0968-0004(93)90092-2</pub-id></citation></ref>
<ref id="B16"><label>16</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Patterson</surname> <given-names>KI</given-names></name> <name><surname>Brummer</surname> <given-names>T</given-names></name> <name><surname>O&#x02019;brien</surname> <given-names>PM</given-names></name> <name><surname>Daly</surname> <given-names>RJ</given-names></name></person-group>. <article-title>Dual-specificity phosphatases: critical regulators with diverse cellular targets</article-title>. <source>Biochem J</source> (<year>2009</year>) <volume>418</volume>(<issue>3</issue>):<fpage>475</fpage>&#x02013;<lpage>89</lpage>.<pub-id pub-id-type="doi">10.1042/BJ20082234</pub-id><pub-id pub-id-type="pmid">19228121</pub-id></citation></ref>
<ref id="B17"><label>17</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dickinson</surname> <given-names>RJ</given-names></name> <name><surname>Keyse</surname> <given-names>SM</given-names></name></person-group>. <article-title>Diverse physiological functions for dual-specificity MAP kinase phosphatases</article-title>. <source>J Cell Sci</source> (<year>2006</year>) <volume>119</volume>(<issue>22</issue>):<fpage>4607</fpage>&#x02013;<lpage>15</lpage>.<pub-id pub-id-type="doi">10.1242/jcs.03266</pub-id><pub-id pub-id-type="pmid">17093265</pub-id></citation></ref>
<ref id="B18"><label>18</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Marti</surname> <given-names>F</given-names></name> <name><surname>Krause</surname> <given-names>A</given-names></name> <name><surname>Post</surname> <given-names>NH</given-names></name> <name><surname>Lyddane</surname> <given-names>C</given-names></name> <name><surname>Dupont</surname> <given-names>B</given-names></name> <name><surname>Sadelain</surname> <given-names>M</given-names></name> <etal/></person-group> <article-title>Negative-feedback regulation of CD28 costimulation by a novel mitogen-activated protein kinase phosphatase, MKP6</article-title>. <source>J Immunol</source> (<year>2001</year>) <volume>166</volume>(<issue>1</issue>):<fpage>197</fpage>&#x02013;<lpage>206</lpage>.<pub-id pub-id-type="doi">10.4049/jimmunol.166.1.197</pub-id><pub-id pub-id-type="pmid">11123293</pub-id></citation></ref>
<ref id="B19"><label>19</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Alonso</surname> <given-names>A</given-names></name> <name><surname>Rahmouni</surname> <given-names>S</given-names></name> <name><surname>Williams</surname> <given-names>S</given-names></name> <name><surname>van Stipdonk</surname> <given-names>M</given-names></name> <name><surname>Jaroszewski</surname> <given-names>L</given-names></name> <name><surname>Godzik</surname> <given-names>A</given-names></name> <etal/></person-group> <article-title>Tyrosine phosphorylation of VHR phosphatase by ZAP-70</article-title>. <source>Nat Immunol</source> (<year>2003</year>) <volume>4</volume>(<issue>1</issue>):<fpage>44</fpage>&#x02013;<lpage>8</lpage>.<pub-id pub-id-type="doi">10.1038/ni856</pub-id><pub-id pub-id-type="pmid">12447358</pub-id></citation></ref>
<ref id="B20"><label>20</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Das</surname> <given-names>SK</given-names></name> <name><surname>Chu</surname> <given-names>WS</given-names></name> <name><surname>Hale</surname> <given-names>TC</given-names></name> <name><surname>Wang</surname> <given-names>X</given-names></name> <name><surname>Craig</surname> <given-names>RL</given-names></name> <name><surname>Wang</surname> <given-names>H</given-names></name> <etal/></person-group> <article-title>Polymorphisms in the glucokinase-associated, dual-specificity phosphatase 12 (DUSP12) gene under chromosome 1q21 linkage peak are associated with type 2 diabetes</article-title>. <source>Diabetes</source> (<year>2006</year>) <volume>55</volume>(<issue>9</issue>):<fpage>2631</fpage>&#x02013;<lpage>9</lpage>.<pub-id pub-id-type="doi">10.2337/db05-1369</pub-id><pub-id pub-id-type="pmid">16936214</pub-id></citation></ref>
<ref id="B21"><label>21</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname> <given-names>X-M</given-names></name> <name><surname>Dormady</surname> <given-names>SP</given-names></name> <name><surname>Chaung</surname> <given-names>W</given-names></name> <name><surname>Basch</surname> <given-names>RS</given-names></name></person-group>. <article-title>mVH1, a dual-specificity phosphatase whose expression is cell cycle regulated</article-title>. <source>Mamm Genome</source> (<year>2000</year>) <volume>11</volume>(<issue>12</issue>):<fpage>1154</fpage>&#x02013;<lpage>6</lpage>.<pub-id pub-id-type="doi">10.1007/s003350010198</pub-id></citation></ref>
<ref id="B22"><label>22</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mu&#x000F1;oz-Alonso</surname> <given-names>MJ</given-names></name> <name><surname>Guillemain</surname> <given-names>G</given-names></name> <name><surname>Kassis</surname> <given-names>N</given-names></name> <name><surname>Girard</surname> <given-names>J</given-names></name> <name><surname>Burnol</surname> <given-names>A-F</given-names></name> <name><surname>Leturque</surname> <given-names>A</given-names></name></person-group>. <article-title>A novel cytosolic dual specificity phosphatase, interacting with glucokinase, increases glucose phosphorylation rate</article-title>. <source>J Biol Chem</source> (<year>2000</year>) <volume>275</volume>(<issue>42</issue>):<fpage>32406</fpage>&#x02013;<lpage>12</lpage>.<pub-id pub-id-type="doi">10.1074/jbc.M000841200</pub-id></citation></ref>
<ref id="B23"><label>23</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sharda</surname> <given-names>PR</given-names></name> <name><surname>Bonham</surname> <given-names>CA</given-names></name> <name><surname>Mucaki</surname> <given-names>EJ</given-names></name> <name><surname>Butt</surname> <given-names>Z</given-names></name> <name><surname>Vacratsis</surname> <given-names>PO</given-names></name></person-group>. <article-title>The dual-specificity phosphatase hYVH1 interacts with Hsp70 and prevents heat-shock-induced cell death</article-title>. <source>Biochem J</source> (<year>2009</year>) <volume>418</volume>(<issue>2</issue>):<fpage>391</fpage>&#x02013;<lpage>401</lpage>.<pub-id pub-id-type="doi">10.1042/BJ20081484</pub-id><pub-id pub-id-type="pmid">18973475</pub-id></citation></ref>
<ref id="B24"><label>24</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cain</surname> <given-names>EL</given-names></name> <name><surname>Braun</surname> <given-names>SE</given-names></name> <name><surname>Beeser</surname> <given-names>A</given-names></name></person-group>. <article-title>Characterization of a human cell line stably over-expressing the candidate oncogene, dual specificity phosphatase 12</article-title>. <source>PLoS One</source> (<year>2011</year>) <volume>6</volume>(<issue>4</issue>):<fpage>e18677</fpage>.<pub-id pub-id-type="doi">10.1371/journal.pone.0018677</pub-id><pub-id pub-id-type="pmid">21556130</pub-id></citation></ref>
<ref id="B25"><label>25</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jeffrey</surname> <given-names>KL</given-names></name> <name><surname>Camps</surname> <given-names>M</given-names></name> <name><surname>Rommel</surname> <given-names>C</given-names></name> <name><surname>Mackay</surname> <given-names>CR</given-names></name></person-group>. <article-title>Targeting dual-specificity phosphatases: manipulating MAP kinase signalling and immune responses</article-title>. <source>Nat Rev Drug Discov</source> (<year>2007</year>) <volume>6</volume>(<issue>5</issue>):<fpage>391</fpage>&#x02013;<lpage>403</lpage>.<pub-id pub-id-type="doi">10.1038/nrd2289</pub-id><pub-id pub-id-type="pmid">17473844</pub-id></citation></ref>
<ref id="B26"><label>26</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Manser</surname> <given-names>E</given-names></name> <name><surname>Huang</surname> <given-names>H-Y</given-names></name> <name><surname>Loo</surname> <given-names>T-H</given-names></name> <name><surname>Chen</surname> <given-names>X-Q</given-names></name> <name><surname>Dong</surname> <given-names>J-M</given-names></name> <name><surname>Leung</surname> <given-names>T</given-names></name></person-group>. <article-title>Expression og constituitively active aPAK reveals the effect of the kinases and focal complexes</article-title>. <source>Mol Cell Biol</source> (<year>1997</year>) <volume>17</volume>:<fpage>1129</fpage>&#x02013;<lpage>43</lpage>.<pub-id pub-id-type="doi">10.1128/MCB.17.3.1129</pub-id></citation></ref>
<ref id="B27"><label>27</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname> <given-names>Y</given-names></name> <name><surname>Blattman</surname> <given-names>JN</given-names></name> <name><surname>Kennedy</surname> <given-names>NJ</given-names></name> <name><surname>Duong</surname> <given-names>J</given-names></name> <name><surname>Nguyen</surname> <given-names>T</given-names></name> <name><surname>Wang</surname> <given-names>Y</given-names></name> <etal/></person-group> <article-title>Regulation of innate and adaptive immune responses by MAP kinase phosphatase 5</article-title>. <source>Nature</source> (<year>2004</year>) <volume>430</volume>(<issue>7001</issue>):<fpage>793</fpage>&#x02013;<lpage>7</lpage>.<pub-id pub-id-type="doi">10.1038/nature02764</pub-id><pub-id pub-id-type="pmid">15306813</pub-id></citation></ref>
<ref id="B28"><label>28</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sekine</surname> <given-names>Y</given-names></name> <name><surname>Yumioka</surname> <given-names>T</given-names></name> <name><surname>Yamamoto</surname> <given-names>T</given-names></name> <name><surname>Muromoto</surname> <given-names>R</given-names></name> <name><surname>Imoto</surname> <given-names>S</given-names></name> <name><surname>Sugiyma</surname> <given-names>K</given-names></name> <etal/></person-group> <article-title>Modulation of TLR4 signaling by a novel adaptor protein signal-transducing adaptor protein-2 in macrophages</article-title>. <source>J Immunol</source> (<year>2006</year>) <volume>176</volume>(<issue>1</issue>):<fpage>380</fpage>&#x02013;<lpage>9</lpage>.<pub-id pub-id-type="doi">10.4049/jimmunol.176.1.380</pub-id><pub-id pub-id-type="pmid">16365431</pub-id></citation></ref>
<ref id="B29"><label>29</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sekine</surname> <given-names>Y</given-names></name> <name><surname>Tsuji</surname> <given-names>S</given-names></name> <name><surname>Ikeda</surname> <given-names>O</given-names></name> <name><surname>Sugiyma</surname> <given-names>K</given-names></name> <name><surname>Oritani</surname> <given-names>K</given-names></name> <name><surname>Shimoda</surname> <given-names>K</given-names></name> <etal/></person-group> <article-title>Signal-transducing adaptor protein-2 regulates integrin-mediated T cell adhesion through protein degradation of focal adhesion kinase</article-title>. <source>J Immunol</source> (<year>2007</year>) <volume>179</volume>(<issue>4</issue>):<fpage>2397</fpage>&#x02013;<lpage>407</lpage>.<pub-id pub-id-type="doi">10.4049/jimmunol.179.4.2397</pub-id><pub-id pub-id-type="pmid">17675501</pub-id></citation></ref>
<ref id="B30"><label>30</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Minoguchi</surname> <given-names>M</given-names></name> <name><surname>Minoguchi</surname> <given-names>S</given-names></name> <name><surname>Aki</surname> <given-names>D</given-names></name> <name><surname>Joo</surname> <given-names>A</given-names></name> <name><surname>Yamamoto</surname> <given-names>T</given-names></name> <name><surname>Yumioka</surname> <given-names>T</given-names></name> <etal/></person-group> <article-title>STAP-2/BKS, an adaptor/docking protein, modulates STAT3 activation in acute-phase response through its YXXQ motif</article-title>. <source>J Biol Chem</source> (<year>2003</year>) <volume>278</volume>(<issue>13</issue>):<fpage>11182</fpage>&#x02013;<lpage>9</lpage>.<pub-id pub-id-type="doi">10.1074/jbc.M211230200</pub-id><pub-id pub-id-type="pmid">12540842</pub-id></citation></ref>
<ref id="B31"><label>31</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Johnson</surname> <given-names>GL</given-names></name> <name><surname>Lapadat</surname> <given-names>R</given-names></name></person-group>. <article-title>Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases</article-title>. <source>Science</source> (<year>2002</year>) <volume>298</volume>(<issue>5600</issue>):<fpage>1911</fpage>&#x02013;<lpage>2</lpage>.<pub-id pub-id-type="doi">10.1126/science.1072682</pub-id><pub-id pub-id-type="pmid">12471242</pub-id></citation></ref>
<ref id="B32"><label>32</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dong</surname> <given-names>C</given-names></name> <name><surname>Davis</surname> <given-names>RJ</given-names></name> <name><surname>Flavell</surname> <given-names>RA</given-names></name></person-group>. <article-title>MAP kinases in the immune response</article-title>. <source>Annu Rev Immunol</source> (<year>2002</year>) <volume>20</volume>(<issue>1</issue>):<fpage>55</fpage>&#x02013;<lpage>72</lpage>.<pub-id pub-id-type="doi">10.1146/annurev.immunol.20.091301.131133</pub-id></citation></ref>
<ref id="B33"><label>33</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname> <given-names>Y-Y</given-names></name> <name><surname>Wu</surname> <given-names>J-W</given-names></name> <name><surname>Wang</surname> <given-names>Z-X</given-names></name></person-group>. <article-title>A distinct interaction mode revealed by the crystal structure of the kinase p38&#x003B1; with the MAPK binding domain of the phosphatase MKP5</article-title>. <source>Sci Signal</source> (<year>2011</year>) <volume>4</volume>:<fpage>ra88</fpage>.<pub-id pub-id-type="doi">10.1126/scisignal.2002241</pub-id></citation></ref>
<ref id="B34"><label>34</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sekine</surname> <given-names>Y</given-names></name></person-group>. <article-title>Adaptor protein STAP-2 modulates cellular signaling in immune systems</article-title>. <source>Biol Pharm Bull</source> (<year>2014</year>) <volume>37</volume>(<issue>2</issue>):<fpage>185</fpage>&#x02013;<lpage>94</lpage>.<pub-id pub-id-type="doi">10.1248/bpb.b13-00421</pub-id><pub-id pub-id-type="pmid">24492713</pub-id></citation></ref>
<ref id="B35"><label>35</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Serbina</surname> <given-names>NV</given-names></name> <name><surname>Jia</surname> <given-names>T</given-names></name> <name><surname>Hohl</surname> <given-names>TM</given-names></name> <name><surname>Pamer</surname> <given-names>EG</given-names></name></person-group>. <article-title>Monocyte-mediated defense against microbial pathogens</article-title>. <source>Annu Rev Immunol</source> (<year>2008</year>) <volume>26</volume>:<fpage>421</fpage>&#x02013;<lpage>52</lpage>.<pub-id pub-id-type="doi">10.1146/annurev.immunol.26.021607.090326</pub-id><pub-id pub-id-type="pmid">18303997</pub-id></citation></ref>
<ref id="B36"><label>36</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Song</surname> <given-names>C-H</given-names></name> <name><surname>Lee</surname> <given-names>J-S</given-names></name> <name><surname>Lee</surname> <given-names>S-H</given-names></name> <name><surname>Lim</surname> <given-names>K</given-names></name> <name><surname>Kim</surname> <given-names>H-J</given-names></name> <name><surname>Park</surname> <given-names>J-K</given-names></name> <etal/></person-group> <article-title>Role of mitogen-activated protein kinase pathways in the production of tumor necrosis factor-&#x003B1;, interleukin-10, and monocyte chemotactic protein-1 by <italic>Mycobacterium tuberculosis</italic> H37Rv-infected human monocytes</article-title>. <source>J Clin Immunol</source> (<year>2003</year>) <volume>23</volume>(<issue>3</issue>):<fpage>194</fpage>&#x02013;<lpage>201</lpage>.<pub-id pub-id-type="doi">10.1023/A:1023309928879</pub-id></citation></ref>
<ref id="B37"><label>37</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hasan</surname> <given-names>Z</given-names></name> <name><surname>Shah</surname> <given-names>B</given-names></name> <name><surname>Mahmood</surname> <given-names>A</given-names></name> <name><surname>Young</surname> <given-names>D</given-names></name> <name><surname>Hussain</surname> <given-names>R</given-names></name></person-group>. <article-title>The effect of mycobacterial virulence and viability on MAP kinase signalling and TNF&#x003B1; production by human monocytes</article-title>. <source>Tuberculosis</source> (<year>2003</year>) <volume>83</volume>(<issue>5</issue>):<fpage>299</fpage>&#x02013;<lpage>309</lpage>.<pub-id pub-id-type="doi">10.1016/S1472-9792(03)00003-9</pub-id></citation></ref>
<ref id="B38"><label>38</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jo</surname> <given-names>EK</given-names></name> <name><surname>Yang</surname> <given-names>CS</given-names></name> <name><surname>Choi</surname> <given-names>CH</given-names></name> <name><surname>Harding</surname> <given-names>CV</given-names></name></person-group>. <article-title>Intracellular signalling cascades regulating innate immune responses to mycobacteria: branching out from toll-like receptors</article-title>. <source>Cell Microbiol</source> (<year>2007</year>) <volume>9</volume>(<issue>5</issue>):<fpage>1087</fpage>&#x02013;<lpage>98</lpage>.<pub-id pub-id-type="doi">10.1111/j.1462-5822.2007.00914.x</pub-id><pub-id pub-id-type="pmid">17359235</pub-id></citation></ref>
</ref-list>
</back>
</article>